Platform Technologies in Drug Discovery and Validation: Volume 50

Goodnow, Robert A.

ISBN 10: 0128130695 / ISBN 13: 9780128130698

Published by Academic Press, 2017

Questo è un articolo print on demand. Seller Inventory # d0243175b416100cf85d6f0f32d34aa5

Synopsis:

Platform Technologies in Drug Discovery and Validation, Volume 50, the latest release in the Annual Reports in Medicinal Chemistry series, provides timely and critical reviews of important topics in medicinal chemistry, with an emphasis on emerging topics in the biological sciences. Topics covered in this new volume include DELT, Oligos: ASO, siRNA, CRISPR, Micro-fluidic chemistry, High throughput screening, Kinase-centric computational drug development, Virtual Screening, Phenotypic screening, PROTACS, Chemical Biology, Fragment-based lead generation, Antibody-Drug Conjugates, Antibody-recruiting small molecules, Deuteration, and Peptides.

• Unique for its treatment of platform technologies for medicinal chemistry and target validation
• Provides a single, rich volume that summaries a broad spectrum of expertise relevant to the field
• Presents state-of-the-art summaries of platform technologies

About the Author: Robert A. Goodnow, Jr. is currently Vice President, Chemistry Innovation at Pharmaron, Inc in Boston, MA. He completed a Ph.D. in bioorganic chemistry at Columbia University, New York, USA, followed by postdoctoral training at Princeton University, New Jersey, USA. He has worked at Roche and AstraZeneca, focusing on new lead and target discovery as well as implementing chemistry technologies in support of early drug discovery. He is the editor and author of The Handbook of DNA-Encoded Chemistry, which was published in 2014 by Wiley.

Bibliographic Details

Title: Platform Technologies in Drug Discovery and ...
Publisher: Academic Press
Publication Date: 2017
Binding: Hardcover
Condition: new